We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+26.7%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.63B
AUM Growth
-$51.2M
Cap. Flow
-$796M
Cap. Flow %
-21.94%
Top 10 Hldgs %
59.45%
Holding
54
New
11
Increased
8
Reduced
25
Closed
10

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$118M
2
MAR icon
Marriott International
MAR
+$62.7M
3
DVA icon
DaVita
DVA
+$61.5M
4
DGX icon
Quest Diagnostics
DGX
+$57.9M
5
UHS icon
Universal Health Services
UHS
+$32.4M

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$158M
2
FLEX icon
Flex
FLEX
+$98.4M
3
HOLX
Hologic
HOLX
+$96.9M
4
FMC icon
FMC
FMC
+$73.4M
5
HCA icon
HCA Healthcare
HCA
+$68.1M

Sector Composition

Rank Sector Weight
1 Healthcare 70.3%
2 Technology 9.78%
3 Consumer Discretionary 6.74%
4 Materials 5.97%
5 Communication Services 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
51
Lowe's Companies
LOW
$122B
– –
-29,630
Closed -$2.55M
MDT icon
52
Medtronic
MDT
$110B
– –
-39,671
Closed -$3.58M
MSFT icon
53
Microsoft
MSFT
$3.71T
– –
-209,477
Closed -$33M
NSP icon
54
Insperity
NSP
$1.96B
– –
-440,733
Closed -$16.4M
1 2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Glenview Capital Management held 54 positions worth $3.63B, down 1.4% from $3.68B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Glenview Capital Management withdrew a net $796M in Q2 2020, closing 10 positions and reducing 25 holdings. Its most notable exit was Flex, an estimated $98.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 69% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Labcorp worth $122M.

  • Glenview Capital Management's largest Q2 2020 buy was Labcorp: 854,427 shares worth $122M.
  • Glenview Capital Management added most to Universal Health Services in Q2 2020, an estimated $32.4M increase.
  • Glenview Capital Management's biggest Q2 2020 reduction was IQVIA, cutting an estimated $158M.
  • Glenview Capital Management fully exited Flex in Q2 2020, selling an estimated $98.4M.
  • Glenview Capital Management's ten largest holdings make up 59% of its $3.63B portfolio in Q2 2020.
  • Glenview Capital Management opened 11 new positions and closed 10 in Q2 2020.
  • Glenview Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.63B.

Based on Glenview Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.